ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 32937 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 32937; 2) Community: the network communities that were significantly associated with the response to NSC 32937; 3) Molecule: the relationships between components within communities and NSC 32937; 4) MDR: the compounds that were significantly associated with the NSC 32937.

NSC Compound Enrichment Correlation
NSC 382050 2,4-Pyrimidinediamine, 5-(3-azido-4-chlorophenyl)- 6-ethyl-, monoethanesulfonate 0.0385067071027343 0.14601278
NSC 382386 2,4-Imidazolidinedione, 3,3'-(1,6-hexanediyl)bis[5,5- diphenyl- 0.0385067071027343 -0.19291748
NSC 46691 Null 0.0385067071027343 -0.2601894
NSC 617823 4-Morpholinepentanoic acid, .alpha.-(phenylmethylene)- .beta.-oxo-, ethyl ester, hydrochloride 0.0385067071027343 0.33582669
NSC 626307 Austrocortirubin 0.0385067071027343 0.15709287
NSC 629868 Null 0.0385067071027343 -0.090550359
NSC 634785 4-Piperidinone, 1-[3-(diethylamino)-1-oxopropyl]-3,5-bis- (phenylmethylene)-, monohydrochloride 0.0385067071027343 0.37652736
NSC 638748 Tetrakis(8-chinolineolato)titanium(IV)-tetrahydrochloride 0.0385067071027343 0.31309976
NSC 639981 Null 0.0385067071027343 0.35969898
NSC 641228 4-(2-fluorophenyl)-2,4-dioxo-3-(3-oxo-1,3-dihydroisobenzofuran-1-yl)-N-o-tolylbutanamide 0.0385067071027343 0.14143195
Total:126  Current:85    [First] [Prev] [Next] [Last]